David Wolinsky, MD

877.463.2010

David Wolinsky, MD

Appointed: 2011

David Wolinsky, MD
Department: Cardiovascular Medicine Florida
Location: Florida, Weston
Mail Code WESTON
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
DeskDesk:954.659.5290
WorkFax:954.659.5292
David Wolinsky, MD
Department: Cardiovascular Medicine
Location: Florida, West Palm Beach
Mail Code WESTON
CityPlace Tower
West Palm Beach, FL 33401
WorkAppointment:877.463.2010
DeskDesk:561.804.0200
WorkFax:561.804.0222
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Wolinsky join the staff of Cleveland Clinic Florida in 2011. He received his undergraduate and M.D. degrees from Columbia University. He carried out his postgraduate training and then spent seven years on staff at St. Luke's Hospital in New York City before joining Albany Associates in Cardiology in Albany, New York where worked from 1989 through 2011. Dr. Wolinsky was director of nuclear cardiology from 1991-2011. He was director of heart failure and director of cardiac Rehabilitation and Wellness at St. Peter's Hospital prior to his arrival at Cleveland clinic.

Dr. Wolinsky is a leader in nuclear cardiology. He is a founding member of the American Society of Nuclear Cardiology. He is a member of its the Board of Directors is and its quality assurance committee. He is an active teacher and lectures at both regional and national meetings. He is actively involved in clinical nuclear cardiology research. He is the founder of the Nuclear Cardiology department at Albany Associates in Cardiology.

Dr. Wolinsky is also involved in heart failure management. He was medical director of the heart failure program at St. Peter's Hospital prior to joining Cleveland Clinic Florida. He was responsible for nursing education and was in charge of the Heart Failure Quality Assurance program.

Dr. Wolinsky is is a champion for community education for heart disease. He lectured frequently on cardiovascular risk reduction and heart failure as part of his role as director of Cardiac Rehab and Wellness.

Professional Highlights

  • Member of Board of Directors-American Society Nuclear Cardiology 2009 to present.
  • Development heart failure transitional care program St. Peters Hospital -2009 -2011.
  • Founder of "A Pair of Hearts"-cardiovascular risk reduction program for women .
  • Lead author Model LCD for payment and appropriate utilization of nuclear cardiology procedures-2011.

Education & Fellowships

Fellowship - Saint Luke's/Roosevelt Hospital Center
Cardiovascular Disease
New York, NY USA
1983
Residency - Saint Luke's/Roosevelt Hospital Center
Internal Medicine
New York, NY USA
1981
Internship - Saint Luke's/Roosevelt Hospital Center
Internal Medicine
New York, NY USA
1979
Medical School - Columbia University College of Physicians & Surgeons
New York, NY USA
1978
Undergraduate - Columbia University
New York, NY USA

Certifications

  • Internal Medicine
  • Internal Medicine- Cardiovascular Disease
  • Certification Board of Nuclear Cardiology- Nuclear Cardiology

Specialty Interests

Nuclear cardiology, heart failure, prevention

Awards & Honors

  • Brian J. McGovern M.D. Excellence in Education Award- 2003.
  • America's Top Doctors- Castle Connelly -2011

Memberships

  • American College of Cardiology
  • American Society of Nuclear Cardiology
  • Heart Failure Society of America

Treatment & Services

  • Abnormal Stress Test
  • Cardiac Rehabilitation
  • Clinical Trials
  • Diagnostic Clinical Cardiology
  • Exercise Counseling
  • General Cardiology
  • Hemodynamic Evaluation
  • Non-Invasive Diagnostic Testing
  • Non-invasive Testing for Vascular Disease
  • Preoperative Evaluation Of Valvular Disease
  • Prevention And Wellness
  • Preventive Cardiology
  • Screening and Testing
  • Second Opinion

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/9/2014, Dr. Wolinsky has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Wolinsky received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Adenosine Therapeutics, LLC
  • Astellas Pharma US, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site